27794108|t|FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
27794108|a|To validate new mitochondrial myopathy serum biomarkers for diagnostic use. We analyzed serum FGF21 (S-FGF21) and GDF15 from patients with (1) mitochondrial diseases and (2) nonmitochondrial disorders partially overlapping with mitochondrial disorder phenotypes. We (3) did a meta-analysis of S-FGF21 in mitochondrial disease and (4) analyzed S-Fgf21 and skeletal muscle Fgf21 expression in 6 mouse models with different muscle - manifesting mitochondrial dysfunctions. We report that S-FGF21 consistently increases in primary mitochondrial myopathy, especially in patients with mitochondrial translation defects or mitochondrial DNA (mtDNA) deletions (675 and 347 pg/mL, respectively; controls: 66 pg/mL, p < 0.0001 for both). This is corroborated in mice (mtDNA deletions 1,163 vs 379 pg/mL, p < 0.0001). However, patients and mice with structural respiratory chain subunit or assembly factor defects showed low induction (human 335 pg/mL, p < 0.05; mice 335 pg/mL, not significant). Overall specificities of FGF21 and GDF15 to find patients with mitochondrial myopathy were 89.3% vs 86.4%, and sensitivities 67.3% and 76.0%, respectively. However, GDF15 was increased also in a wide range of nonmitochondrial conditions. S-FGF21 is a specific biomarker for muscle - manifesting defects of mitochondrial translation, including mitochondrial transfer-RNA mutations and primary and secondary mtDNA deletions, the most common causes of mitochondrial disease. However, normal S-FGF21 does not exclude structural respiratory chain complex or assembly factor defects, important to acknowledge in diagnostics. This study provides Class III evidence that elevated S-FGF21 accurately distinguishes patients with mitochondrial myopathies from patients with other conditions, and FGF21 and GDF15 mitochondrial myopathy from other myopathies.
27794108	0	5	FGF21	T103	UMLS:C3887831
27794108	11	20	biomarker	T201	UMLS:C0005516
27794108	25	50	mitochondrial translation	T038	UMLS:C2245743
27794108	55	60	mtDNA	T103	UMLS:C0012929
27794108	73	82	disorders	T038	UMLS:C0012634
27794108	99	121	mitochondrial myopathy	T017	UMLS:C0162670
27794108	122	127	serum	T031	UMLS:C0229671
27794108	128	138	biomarkers	T201	UMLS:C0005516
27794108	143	157	diagnostic use	T058	UMLS:C0011933
27794108	162	170	analyzed	T062	UMLS:C0936012
27794108	171	176	serum	T031	UMLS:C0229671
27794108	177	182	FGF21	T103	UMLS:C3887831
27794108	184	191	S-FGF21	T103	UMLS:C3887831
27794108	197	202	GDF15	T103	UMLS:C1431343
27794108	226	248	mitochondrial diseases	T038	UMLS:C0751651
27794108	257	283	nonmitochondrial disorders	T038	UMLS:C0012634
27794108	311	333	mitochondrial disorder	T038	UMLS:C0751651
27794108	359	372	meta-analysis	T062	UMLS:C0920317
27794108	376	383	S-FGF21	T103	UMLS:C3887831
27794108	387	408	mitochondrial disease	T038	UMLS:C0751651
27794108	417	425	analyzed	T062	UMLS:C0936012
27794108	426	433	S-Fgf21	T103	UMLS:C3887831
27794108	438	453	skeletal muscle	T017	UMLS:C0242692
27794108	454	459	Fgf21	T103	UMLS:C3887831
27794108	460	470	expression	T038	UMLS:C0017262
27794108	476	481	mouse	T204	UMLS:C0025929
27794108	482	488	models	T204	UMLS:C0599779
27794108	504	510	muscle	T017	UMLS:C0026845
27794108	525	551	mitochondrial dysfunctions	T033	UMLS:C4021734
27794108	568	575	S-FGF21	T103	UMLS:C3887831
27794108	610	632	mitochondrial myopathy	T017	UMLS:C0162670
27794108	662	687	mitochondrial translation	T038	UMLS:C2245743
27794108	688	695	defects	T017	UMLS:C0000768
27794108	699	734	mitochondrial DNA (mtDNA) deletions	T033	UMLS:C4313882
27794108	835	839	mice	T204	UMLS:C0025929
27794108	841	856	mtDNA deletions	T033	UMLS:C4313882
27794108	912	916	mice	T204	UMLS:C0025929
27794108	922	985	structural respiratory chain subunit or assembly factor defects	T017	UMLS:C0000768
27794108	1008	1013	human	T204	UMLS:C0086418
27794108	1035	1039	mice	T204	UMLS:C0025929
27794108	1051	1066	not significant	T033	UMLS:C1273937
27794108	1094	1099	FGF21	T103	UMLS:C3887831
27794108	1104	1109	GDF15	T103	UMLS:C1431343
27794108	1132	1154	mitochondrial myopathy	T017	UMLS:C0162670
27794108	1234	1239	GDF15	T103	UMLS:C1431343
27794108	1307	1314	S-FGF21	T103	UMLS:C3887831
27794108	1329	1338	biomarker	T201	UMLS:C0005516
27794108	1343	1349	muscle	T017	UMLS:C0026845
27794108	1364	1371	defects	T017	UMLS:C0000768
27794108	1375	1400	mitochondrial translation	T038	UMLS:C2245743
27794108	1412	1425	mitochondrial	T017	UMLS:C0026237
27794108	1426	1438	transfer-RNA	T103	UMLS:C0035711
27794108	1439	1448	mutations	T038	UMLS:C0026882
27794108	1475	1490	mtDNA deletions	T033	UMLS:C4313882
27794108	1518	1539	mitochondrial disease	T038	UMLS:C0751651
27794108	1557	1564	S-FGF21	T103	UMLS:C3887831
27794108	1570	1573	not	T033	UMLS:C1513916
27794108	1582	1645	structural respiratory chain complex or assembly factor defects	T017	UMLS:C0000768
27794108	1675	1686	diagnostics	T058	UMLS:C0430022
27794108	1693	1698	study	T062	UMLS:C2603343
27794108	1708	1717	Class III	T170	UMLS:C0441887
27794108	1741	1748	S-FGF21	T103	UMLS:C3887831
27794108	1788	1812	mitochondrial myopathies	T017	UMLS:C0162670
27794108	1854	1859	FGF21	T103	UMLS:C3887831
27794108	1864	1869	GDF15	T103	UMLS:C1431343
27794108	1870	1892	mitochondrial myopathy	T017	UMLS:C0162670
27794108	1904	1914	myopathies	T038	UMLS:C0026848